Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium - canine distemper virus, live, strain n-cdv = 10exp3.0 ccid50/do; canine parainfluenzavirus (live, attenuated) = 10exp6.0 ccid50/dose; leptospira interrogans serogroup canicola (inactivated) = 40 hpu/dose; canine adenovirus 2 (live, attenuated) = 10exp3.2 ccid50/dose; leptospira interrogans serogroup icterohaemorrhagiae (inactivated) = 40 hpu/dose; canine parvovirus (live, attenuated) = 10exp7.0 ccid50/dose - lyophilisate and solvent for suspension for injection - leptospira interrogans canicola; leptospira interrogans icterohaemorrhagiae; canine parvovirus; canine parainfluenza virus; canine adenovirus type 2; canine distemper virus, live, strain n-cdv - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira - dog

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine parainfluenza virus , canine adenovirus (cav) , canine parvovirus , inactivated leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola , l. kirschneri ser. grippotyphosa , l. interrogans ser. bratislava , rabies virus vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each dose (1 ml) contains: canine distemper virus (cdv bio 11/a strain)- 10^3.1 to 10^5.1 tcid50 canine parainfluenza type 2 virus (cpiv-2-bio 15 strain)-- 10^3.1 to 10^5.1 tcid50 canine adenovirus type 2 (cav-2-bio 13 strain)-10^3.6 to 10^5.3 tcid50 canine parvovirus type 2b (cpv-2b bio 12/b strain)-10^4.3 to 10^6.6 tcid50 leptospira interrogans ser. icterohaemorrhagiae (mslb 1089 strain)- >1:51 alr (gmt) ser. canicola (mslb 1090 strain)-- >1:51 alr (gmt) ser. bratislava (mslb 1088 strain)- >1:51 alr (gmt) leptospira kirschneri ser. grippotyphosa (mslb 1091 strain)- >1:40 alr (gmt) rabies virus (sad vnukovo-32 bio 16 strain)-> 2.0 iu tcid-tissue culture infect dose 50% gmt-geometric moon titre alr-agglutination lyuis reacties

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

virbac s.a. - leptospira interrogans serogroup canicola (inactivated) 4350 elisa u - 7330 elisa u; leptospira interrogans serogroup icterohaemorrhagiae (inactivated) 4250 elisa u - 6910 elisa u; canine parainfluenzavirus (live, attenuated) - lyophilisate and suspension for suspension for injection - leptospira interrogans canicola; leptospira interrogans icterohaemorrhagiae; canine parainfluenza virus - live canine parainfluenza virus + inactivated leptospira - dog

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - canine distemper virus (live, attenuated) ; leptospira kirschneri serovar gryppotyphosa (inactivated) ; canine adenovirus 2 (live, attenuated) ; leptospira interrogans serovar icterohaemorrhagiae (inactivated) ; leptospira interrogans serogroup canicola (inactivated) ; canine parainfluenzavirus (live, attenuated) ; canine parvovirus (live, attenuated) - lyophilisate and suspension for suspension for injection - leptospira interrogans canicola; leptospira interrogans icterohaemorrhagiae; leptospira interrogans grippotyphosa; canine adenovirus type 2; canine distemper virus (cdv); canine parvovirus type 2; canine parainfluenza virus type 2 - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira - dog

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium - leptospira interrogans serogroup canicola (inactivated) = 40 hpu/do; canine parvovirus (live, attenuated) = 10exp7.0 ccid50/dose; leptospira interrogans serogroup icterohaemorrhagiae (inactivated) 40 u/dose - suspension for injection - leptospira interrogans icterohaemorrhagiae; leptospira interrogans canicola; canine parvovirus - canine parvovirus + leptospira - dog

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - leptospirosis - dog - leptospira icterohaemorrhagiae; canine adeno virus type 2; canine coronavirus vaccine - antigen; canine distemper virus strain onderstepoort; canine parvo virus - misc. vaccines or anti sera - leptospirosis - dog - leptospira icterohaemorrhagiae vaccine active 0.0 u; canine adeno virus type 2 vaccine-viral active 0.0 u; canine coronavirus vaccine - antigen vaccine-viral active 0.0 u; canine distemper virus strain onderstepoort vaccine-viral active 0.0 u; canine parvo virus vaccine-viral active 0.0 u - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | parvovirus